RHHBY - Kronos cuts 21% of workforce extends cash runway into 2H 2026 March, 07 2024 04:37 PM Roche Holding Ltd ADR 2024-03-07 16:37:27 ET More on Kronos Bio Kronos Bio streamlines leadership, cuts CMO, CSO and COO roles Kronos ends development of lanraplenib combo therapy for AML Seeking Alpha’s Quant Rating on Kronos Bio Historical earnings data for Kronos Bio Financial information for Kronos Bio For further details see: Kronos cuts 21% of workforce, extends cash runway into 2H 2026